Understanding how bone heals in mice with Down syndrome
Investigating injury response and bone regeneration in Down syndrome mouse models
This study is looking at how bone injuries heal in mice with Down syndrome to find out if certain treatments can help improve bone repair, which could lead to better care for people with Down syndrome when they have bone injuries.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10916200 on NIH RePORTER |
What this research studies
This research investigates how bone injury and healing processes are affected in mouse models of Down syndrome, which is caused by an extra copy of chromosome 21. The study focuses on the role of specific signaling molecules, particularly PGE2, in bone regeneration and healing. By examining the effects of pharmaceutical treatments at various stages of the healing process, the researchers aim to identify potential ways to enhance bone repair in individuals with Down syndrome. This work could provide insights into the unique challenges faced by this population regarding bone health and recovery from injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Down syndrome who may experience delayed bone healing or have a history of bone fractures.
Not a fit: Patients without Down syndrome or those who do not have issues related to bone healing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for bone healing in individuals with Down syndrome, potentially reducing their risk of fractures and enhancing their overall bone health.
How similar studies have performed: Previous research has shown promising results in understanding bone healing mechanisms in other populations, but this specific approach in Down syndrome models is relatively novel.
Where this research is happening
College Station, United States
- Texas A&m University — College Station, United States (Active)
Researchers
- Principal investigator: Sherman, Kirby M. — Texas A&m University
- Study coordinator: Sherman, Kirby M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.